Mandate

Vinge represented affiliates of American Industrial Partners in entering into an agreement to acquire Veoneer’s Restraint Control Systems business from SSW Partners

Veoneer is the world leader in automotive electronic restraint control systems and has sold more than 1 billion electronic control units and crash sensors. Veoneer’s scalable, best-in-class restraint control systems are saving lives by mitigating the effects of car crashes. In 2023, the company’s products are part of more than 40 scheduled vehicle launches. The company has approximately 2,700 employees in 11 countries.

AIP is a middle market private equity firm focused on industrial businesses. The firm manages over $16 billion on behalf of its limited partners and invests in the aerospace and defense, automotive, building products, capital goods, chemicals, industrial services, industrial technology, logistics, metals and mining, transportation and other sectors.

Vinges team consisted of Ulrich Ziche (M&A), Daniel Wendelson, Hilda Ivarsson, Alva Chambert (EU, Competition and Regulatory), Simon Söderholm (Employment & Benefits) and Marcus Eklund (Investigations & International Disputes).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025